80.51 USD
↗ 0.00 (0.00%)AT CLOSE (11:59 AM EDT)
Dianthus Therapeutics, Inc. Common Stock
DNTHNASDAQ • USD
80.50
↘ 0.01 (0.01%)
POST MARKET (AS OF 04:42 PM EDT)
Post Market
AS OF 04:42 PM EDT
80.50
↘ 0.01 (0.01%)
Market: CLOSED
Open?$84.03
High?$85.82
Low?$79.64
Prev. Close?$80.51
Volume?835.9K
Avg. Volume?567.3K
VWAP?$81.22
Rel. Volume?1.47x
Bid / Ask
Bid?$45.00 × 600
Ask?$89.50 × 100
Spread?$44.50
Midpoint?$67.25
Valuation & Ratios
Market Cap?4.4B
Shares Out?54.7M
Float?50.4M
Float %?92.6%
P/E Ratio?N/A
P/B Ratio?3.66
EPS?-$3.18
Dividend?0.00%
Ex-Dividend?N/A
Dianthus Therapeutics, Inc. Common Stock (DNTH) trades at $80.47 per share. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.
Employees
92
Market Cap
4.4B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2023-09-12
Address
7 TIMES SQUARE
NEW YORK, NY 10036
Phone: 929-999-4055
NEW YORK, NY 10036
Phone: 929-999-4055
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?6
Z-Score?100
Momentum?23
Short Sent.?28
Piotroski F-Score?1/9Weak
Altman Z-Score?58.06Safe
Confidence?55%Low
Short InterestVery High
Short % of Float?12.75%High
Short Interest?6.4M
Days to Cover?14.3
Free Float50.4M
Avg Daily Volume450.6K
Settlement Date2026-05-15
Financial Health
Current Ratio?29.25Strong
Quick Ratio?29.25Strong
Cash Ratio?16.40Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?3.66FAIR▾
Peers100
S&P47
P/S?3,294.30HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-19.7CHEAP▾
S&P97
EV/Sales?2,824.48HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-14.5%WEAK▾
S&P9
ROA?-13.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-130485000
Enterprise Value?$3.8B
Fundamentals ratios updated end of day